+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011



Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011



Sexually Transmitted Diseases 41(2): 89-93



A quadrivalent vaccine that prevents genital warts (GWs) has been recommended by the Advisory Committee on Immunization Practices for women since 2007 and for men since 2011. National estimates of GW burden in sexually transmitted disease (STD) clinic settings are useful to provide a baseline assessment to monitor and evaluate reductions in GW and serve as an important early measure of human papillomavirus (HPV) vaccine impact in this population. Genital wart prevalence among STD clinic patients from January 2010 to December 2011 was determined from a cross-sectional analysis of all patients attending STD clinics in the STD Surveillance Network (SSuN). We conducted bivariate analyses for women, men who have sex with women (MSW), and men who have sex with men (MSM) separately, using χ statistics for the association between GW diagnosis and demographic, behavioral, and clinical characteristics. Among 241,630 STD clinic patients, 13,063 (5.4%) had GWs. Wide regional differences were observed across SSuN sites. The prevalence of GW was as follows: 7.5% among MSW (range by SSuN site, 3.9-15.2), 7.5% among MSM (range, 3.3-20.6), and 2.4% among women (range, 1.2-5.4). The highest rate was among 25- to 29-year-old MSW (9.8%). Non-Hispanic black women and MSW had a lower prevalence of GWs than did women and MSW in other racial/ethnic groups. There is a significant burden of GW in STD clinic populations, most notably in men. Given the opportunity for prevention with a quadrivalent HPV vaccine, STD clinics may be an ideal setting for monitoring trends in GW prevalence among men (MSW and MSM). However, given the observed low GW prevalence among female STD clinic patients, STD clinics may not provide an appropriate setting to monitor the impact of HPV vaccine among women.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055158022

Download citation: RISBibTeXText

PMID: 24413486

DOI: 10.1097/olq.0000000000000077


Related references

Trends of Anogenital Warts Among Sexually Transmitted Disease Clinic Patients - Sexually Transmitted Disease Surveillance Network, United States, 2010-2016. Journal of Infectious Diseases 2018, 2018

Management of Pelvic Inflammatory Disease in Selected U.S. Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011. Sexually Transmitted Diseases 42(8): 429-433, 2015

The efficacy of behavioral interventions in reducing HIV risk sex behaviors and incident sexually transmitted disease in black and Hispanic sexually transmitted disease clinic patients in the United States: a meta-analytic review. Sexually Transmitted Diseases 34(6): 319-332, 2007

Comparison of sexually transmitted disease prevalence by reported level of condom use among patients attending an urban sexually transmitted disease clinic. Sexually Transmitted Diseases 31(3): 154-160, 2004

The prevalence of psychiatric disorders in sexually transmitted disease clinic patients and their association with sexually transmitted disease risk. Sexually Transmitted Diseases 31(1): 8, 2004

From the Centers for Disease Control and Prevention. Impact of closure of a sexually transmitted disease clinic on public health surveillance of sexually transmitted diseases--Washington, D.C., 1995. JAMA 281(2): 127-128, 1999

Impact of closure of a sexually transmitted disease clinic on public health surveillance of sexually transmitted diseases--Washington, D.C., 1995. Mmwr. Morbidity and Mortality Weekly Report 47(49): 1067-1069, 1999

New Human Immunodeficiency Virus Diagnoses Among Men Who Have Sex With Men Attending Sexually Transmitted Disease Clinics, STD Surveillance Network, January 2010 to June 2013. Sexually Transmitted Diseases 45(9): 577-582, 2018

Reported sexually transmitted disease clinic attendance and sexually transmitted infections in britain: prevalence, risk factors, and proportionate population burden. Journal of Infectious Diseases 191(Suppl. 1): S127-S138, 2005

Non-ulcerative sexually transmitted disease and human immunodeficiency virus infection in patients attending a sexually transmitted disease clinic in Jamaica. West Indian Medical Journal 53(1): 55-56, 2004

Comparison of sexually transmitted disease prevalence by reported condom use: errors among consistent condom users seen at an urban sexually transmitted disease clinic. Sexually Transmitted Diseases 31(9): 526-532, 2004

Seroprevalence of HIV infection among sexually transmitted disease clinic attenders. Study Group of the Seroprevalence of Anonymous HIV Unrelated to Patients Consulting a Sexually Transmitted Disease Clinic. Medicina Clinica 114(6): 211-213, 2000

Understanding the Effects of Forced Sex on Sexually Transmitted Disease Acquisition and Sexually Transmitted Disease Care: Findings From the National Survey of Family Growth (2011-2013). Sexually Transmitted Diseases 44(10): 613-618, 2017

The prevalence of hepatitis G virus in persons attending a sexually transmitted disease clinic compared with persons who never had a sexually transmitted disease. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 358, 1998

Prevalence And Clinical Manifestations Of Male Patients With Anogenital Warts Attending A Sexually Transmitted Disease Clinic Prior Hpv Vaccine Recommendation. Southeast Asian Journal of Tropical Medicine and Public Health 45(6): 1337-1343, 2015